Post-Hypoxic Regulation of GABA-A Receptor Function

GABA-A 受体功能的缺氧后调节

基本信息

项目摘要

DESCRIPTION (provided by applicant): Stroke and hypoxia frequently cause seizures or myoclonus, disorders of excessive neuronal excitability. Hypoxia-induced hyperexcitability is linked to dysfunction of inhibitory GABAA receptors (GABAARs), but the underlying mechanisms are poorly understood. GABAARs are chloride channels activated by gamma-aminobutyric acid (GABA), composed of subunits that determine their pharmacology and kinetic properties. We have studied the effects of hypoxia on GABAAR function and subunit mRNA expression in NT2-N neuronal cells and primary cortical neurons in vitro. Maximal GABA-evoked currents increased 1 h after transient hypoxia but then decreased to 60% of control after 48 h, associated with reductions in alpha-1, alpha-5, beta-2 and gamma-2 subunit mRNAs. These changes are associated with induction of the bHLH transcription factor, hypoxia-inducible factor-1alpha (HIF1a) and calcium entry via voltage-gated channels opened by hypoxia-induced depolarizaton. Our long-term goal is to understand the mechanisms of hypoxia-induced GABAAR neuroplasticity, with these specific aims: 1. Determine the mechanisms underlying the early increase in GABAAR current after hypoxia. Hypothesis 1 is that the initial increase in GABAAR current is related to increased GABAAR channel density or phosphorylation. We will use whole-cell, perforated patch and single channel recordings to measure GABAAR currents, pharmacology, and single channel properties of post-hypoxic GABAAR currents. 2. Determine whether transcriptional changes account for the late reduction in GABAAR currents. Hypothesis 2 is that the reduction in GABAAR currents 48 h after hypoxia is related to altered GABAAR subunit transcription, and that specific subunit changes account for altered GABAAR pharmacology. We will use whole-cell recordings and RT-PCR to assess changes in GABAAR pharmacology and subunit expression. 3. Determine whether HIF-1a is involved in altered GABAAR subunit expression. Hypothesis 3 is that hypoxic induction of HIF-1a participates in regulating GABAAR subunit expression in concert with other signaling mechanisms. We will determine a. whether hypoxia alters HIF-1a expression, b. whether elevated HIF-1a reproduces hypoxia-related GABAR changes, and c. whether voltage-gated calcium channels mediate GABAAR regulation. These studies implicate a novel mechanism underlying post- hypoxic hyperexcitability, and could result in new treatments for post-hypoxic seizures and myoclonus.
描述(由申请人提供):中风和缺氧经常引起癫痫发作或肌阵挛,神经兴奋性过度紊乱。缺氧诱导的高兴奋性与抑制性GABAA受体(GABAARs)功能障碍有关,但其潜在机制尚不清楚。GABAARs是由γ -氨基丁酸(GABA)激活的氯离子通道,由亚基组成,决定其药理学和动力学性质。我们在体外研究了缺氧对NT2-N神经元细胞和原代皮层神经元GABAAR功能和亚基mRNA表达的影响。短暂缺氧后1小时最大gaba诱发电流增加,但48小时后下降至对照组的60%,与α -1、α -5、β -2和γ -2亚基mrna减少有关。这些变化与bHLH转录因子、缺氧诱导因子-1 α (HIF1a)的诱导和钙通过缺氧诱导去极化打开的电压门控通道进入有关。我们的长期目标是了解缺氧诱导GABAAR神经可塑性的机制,具体目标如下:1。确定缺氧后GABAAR电流早期升高的机制。假设1:GABAAR电流的初始增加与GABAAR通道密度增加或磷酸化有关。我们将使用全细胞、穿孔贴片和单通道记录来测量GABAAR电流、药理学和缺氧后GABAAR电流的单通道特性。2. 确定转录变化是否解释了GABAAR电流的晚期减少。假设2:缺氧后48小时GABAAR电流的减少与GABAAR亚基转录的改变有关,特定亚基的改变解释了GABAAR药理学的改变。我们将使用全细胞记录和RT-PCR来评估GABAAR药理学和亚基表达的变化。3. 确定HIF-1a是否参与GABAAR亚基表达的改变。假设3:缺氧诱导HIF-1a与其他信号机制一起参与GABAAR亚基表达的调节。我们将确定a.缺氧是否会改变HIF-1a表达,b. HIF-1a升高是否会重现缺氧相关的GABAR变化,c.电压门控钙通道是否介导GABAAR调节。这些研究暗示了缺氧后高兴奋性的新机制,并可能导致缺氧后癫痫发作和肌阵挛的新治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lazar John GREENFIELD其他文献

Lazar John GREENFIELD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lazar John GREENFIELD', 18)}}的其他基金

Post-Hypoxic Regulation of GABA-A Receptor Function
GABA-A 受体功能的缺氧后调节
  • 批准号:
    7342022
  • 财政年份:
    2006
  • 资助金额:
    $ 26.69万
  • 项目类别:
Post-Hypoxic Regulation of GABA-A Receptor Function
GABA-A 受体功能的缺氧后调节
  • 批准号:
    7546993
  • 财政年份:
    2006
  • 资助金额:
    $ 26.69万
  • 项目类别:
Post-Hypoxic Regulation of GABA-A Receptor Function
GABA-A 受体功能的缺氧后调节
  • 批准号:
    7157555
  • 财政年份:
    2006
  • 资助金额:
    $ 26.69万
  • 项目类别:
REGULATION OF CLONED GABA RECEPTORS BY PHOSPHORYLATION
通过磷酸化调节克隆的 GABA 受体
  • 批准号:
    2259684
  • 财政年份:
    1993
  • 资助金额:
    $ 26.69万
  • 项目类别:
REGULATION OF CLONED GABA RECEPTORS BY PHOSPHORYLATION
通过磷酸化调节克隆的 GABA 受体
  • 批准号:
    2431066
  • 财政年份:
    1993
  • 资助金额:
    $ 26.69万
  • 项目类别:
REGULATION OF CLONED GABA RECEPTORS BY PHOSPHORYLATION
通过磷酸化调节克隆的 GABA 受体
  • 批准号:
    2259685
  • 财政年份:
    1993
  • 资助金额:
    $ 26.69万
  • 项目类别:

相似国自然基金

rhIL-1Ra防治肿瘤化疗所致中性粒细胞减少症的药理机制研究
  • 批准号:
    81173113
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目

相似海外基金

Mechanism and Countermeasure of Carfentanil-induced Respiratory Disorder and Death
卡芬太尼引起呼吸系统疾病及死亡的机制及对策
  • 批准号:
    10743181
  • 财政年份:
    2023
  • 资助金额:
    $ 26.69万
  • 项目类别:
Serotonin Based Therapeutics in Cerebral Palsy
基于血清素的脑瘫治疗
  • 批准号:
    10701186
  • 财政年份:
    2023
  • 资助金额:
    $ 26.69万
  • 项目类别:
Treatment of Inflammatory Complications of Viral Pneumonia
病毒性肺炎炎症并发症的治疗
  • 批准号:
    10383991
  • 财政年份:
    2022
  • 资助金额:
    $ 26.69万
  • 项目类别:
Adenosine receptor 2A in subretinal fibrosis
腺苷受体2A在视网膜下纤维化中的作用
  • 批准号:
    10417359
  • 财政年份:
    2022
  • 资助金额:
    $ 26.69万
  • 项目类别:
The role of cholesterol metabolic enzyme CYP46A1 and its metabolite 24S-hydroxycholesterol in ischemic stroke.
胆固醇代谢酶CYP46A1及其代谢物24S-羟基胆固醇在缺血性脑卒中中的作用。
  • 批准号:
    10503336
  • 财政年份:
    2022
  • 资助金额:
    $ 26.69万
  • 项目类别:
Discovery of Adenosine Receptor Allosteric Modulators for Cardiovascular Disease and Inflammation
发现用于心血管疾病和炎症的腺苷受体变构调节剂
  • 批准号:
    10464473
  • 财政年份:
    2022
  • 资助金额:
    $ 26.69万
  • 项目类别:
Fetal cerebral arteries and prenatal alcohol exposure
胎儿脑动脉和产前酒精暴露
  • 批准号:
    10337722
  • 财政年份:
    2022
  • 资助金额:
    $ 26.69万
  • 项目类别:
Retinal vasculature in hypertension
高血压患者的视网膜血管
  • 批准号:
    10367158
  • 财政年份:
    2022
  • 资助金额:
    $ 26.69万
  • 项目类别:
Synergistic white matter injury from diesel exhaust particulate and chronic cerebral hypoperfusion exposures: Interaction between the Nogo/NgR1 receptor pathway and extravascular fibrinogen toxicity
柴油机尾气颗粒和慢性脑灌注不足导致的协同白质损伤:Nogo/NgR1 受体途径与血管外纤维蛋白原毒性之间的相互作用
  • 批准号:
    10591353
  • 财政年份:
    2022
  • 资助金额:
    $ 26.69万
  • 项目类别:
HIFs in osteocytes
骨细胞中的 HIF
  • 批准号:
    10631462
  • 财政年份:
    2022
  • 资助金额:
    $ 26.69万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了